Skip to main content
Premium Trial:

Request an Annual Quote

QIMR Installs Bruker Daltonics' maXis Mass Spectrometer

NEW YORK (GenomeWeb News) — The Queensland Institute of Medical Research has installed one of Bruker Daltonics’ mass spectrometers for use in its proteomics research, Bruker said today.
 
QIMR, located in Brisbane, Australia, will use the company’s maXis instruments in its Protein Discovery Center. The maXis system is used in quantitative proteomics, peptide and intact protein analysis, and small molecule identification.
 
Bruker said that this agreement marks the first installation of this high-resolution, time-of-flight model in the Australasia region.
 
Bruker Daltonics Executive VP Clive Seymour called the installation “a major opportunity for us to co-develop a wide range of applications undertaken” at the PDC.
 
“In particular, it will provide the PDC with the scope to collaborate more effectively with scientists from QIMR, Australia and internationally on projects aimed at combating infectious diseases and cancer,” explained PDC Director Jeff Gorman in a statement.
 
Financial terms of the agreement were not released.
 

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.